Real-time enrollment status for this carcinoid syndrome clinical trial
Current Status
Active, Not Recruiting
Checked: October 16, 2026 at 3:50 PM UTC
| NCT Number | NCT07087054 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Carcinoid Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 141 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Crinetics Pharmaceuticals Inc. |
| Last Updated on CT.gov | October 15, 2026 (Yesterday) |
As of October 16, 2026: Clinical trial NCT07087054 is currently active_not_recruiting participants. This phase3 study for carcinoid syndrome is not currently accepting new participants at 17 locations across the United States. The study is sponsored by Crinetics Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07087054 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07087054 was last updated Yesterday (October 15, 2026). HelloStudys verifies this status automatically.